Labor drug pause may protect newborns
NCT ID NCT03991091
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether turning off the labor drug oxytocin once a woman reaches 6 cm dilation (active labor) could lower the chance of newborn complications. Over 2,400 women with a single, full-term baby in head-down position took part. The goal was to see if this simple change in drug timing could improve newborn health outcomes like breathing, blood acidity, and need for intensive care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL MORBIDITY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
hospital Cochin; port royal Maternity unit
Paris, 75014, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.